Dawaa Drug Store Llc Pharmaceutical Import Profile — United Arab Emirates (DGFT 2022–2026)

Name: Dawaa Drug Store Llc Pharmaceutical Import Records from India — 4 Products, $104.8K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Dawaa Drug Store Llc — Pharmaceutical Importer Profile (2026) | 4 Products, $104.8K Trade | TransData Nexus

Dawaa Drug Store Llc

Pharmaceutical Importer · United Arab Emirates · Diabetes & Endocrine Focus · $104.8K Total Trade · DGFT Verified

Dawaa Drug Store Llc is a pharmaceutical importer based in United Arab Emirates with a total trade value of $104.8K across 4 products in 4 therapeutic categories. Based on 60 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Dawaa Drug Store Llc sources from 2 verified Indian suppliers, with Anr Health Care Private Limited accounting for 99.9% of imports.

Dawaa Drug Store Llc — Import Portfolio & Supplier Network

Dawaa Drug Store Llc import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Dawaa Drug Store Llc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Anr Health Care Private Limited	$2.5M	1,962	99.9%
Rgsk Canada Healthcare Inc	$2.9K	1	0.1%

Dawaa Drug Store Llc sources from 2 verified Indian suppliers across 1,549 distinct formulations. The sourcing is highly concentrated — Anr Health Care Private Limited accounts for 99.9% of total imports, indicating a strategic single-source relationship.

What Formulations Does Dawaa Drug Store Llc Import?

Formulation	Value	Ships
Tecfidera 240MG cap salt dimethyl fumarate b mhls700 m 08/22 e	$67.2K	2
Tresiba flextouch pen insulin degludec 100iu/ML batch no np5f561 manufacturing dt 01/2023exp	$55.0K	2
Eylea 40MG/ML aflibercept 40MG batch no kt0kfap manufacturing dt 04/23 exp	$52.5K	2
Exemptia 40MG INJ adalimumab 40MG injb:b300417 b300478 b300487 manufacturing :08/2309/23 exp: 07/26	$50.0K	1
Moxovas 0.3 moxonidine 0.3MG batch kmh2311a manufacturing jun.2023 exp	$43.9K	3
Infimab infliximab 100MG b: rlin23-001 m: 01/23 e	$34.4K	1
Bdrelin 11.25 triptorelin b: btrbl0223 m: jan-23 e	$32.0K	4
Jardiance 25 MG empagliflozin b: 22g2705 m: sep.2022 e	$30.0K	8
Trimetazidine modified release tablets IP-b/no.:me052310m/dt:08/2023e/dt.:07/2026	$27.7K	2
Iromac-fcm INJ 500 MG batch no. es0924001 mfg. jan-24 exp.	$25.5K	1
Vildalip m 1000 vildagliptin and metformin b vlpmc23001 m 23-apr e	$24.3K	2
Vildacast - m 1000 vildaglptin + metformin batch pgt23 - 1358a manufacturing 23-aug exp	$22.1K	1
Urocalculai TAB bethanechol (25MG) b t2609a23 m apr-23 e may	$20.5K	1
Victoza liraclitide b ns6js96 m may-23e	$20.3K	1
Empagliflozin tablets 25MG brand name: gibtulio 25 tablets b.no 22k2236 manufacturing 11/2022 exp	$20.3K	1

Dawaa Drug Store Llc imports 1,549 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Empagliflozin	Diabetes & Endocrine	$83.4K	49	1.2%	15
2	Ustekinumab	Biologics & Immunotherapy	$17.9K	3	1.4%	8
3	Nilotinib	Advanced Oncology	$2.4K	4	0.2%	7
4	Levodopa Carbidopa	Combination Drugs	$1.1K	4	14.5%	2

Dawaa Drug Store Llc imports 4 pharmaceutical products across 4 categories into United Arab Emirates totaling $104.8K.

Dawaa Drug Store Llc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Dawaa Drug Store LLC is a reputable medical distribution company headquartered in Abu Dhabi, United Arab Emirates. Established in 2023, the company has swiftly positioned itself as a trusted partner in the UAE's pharmaceutical sector. Dawaa Drug Store specializes in the procurement and distribution of a diverse range of high-quality pharmaceutical products, ensuring their availability to healthcare professionals, hospitals, clinics, and pharmacies across the region. The company's commitment to quality is evident in its partnerships with reputable manufacturers and suppliers, adhering to stringent quality standards and regulatory requirements.

The company's primary focus is on delivering a wide array of medications and healthcare supplies to meet the diverse needs of the healthcare community. Dawaa Drug Store operates with a strong emphasis on reliability and timely service, supported by a robust supply chain and logistics network that facilitates efficient product delivery throughout Abu Dhabi and its surrounding regions. This operational efficiency is underpinned by a dedicated team of professionals possessing in-depth knowledge and expertise in the pharmaceutical industry, ensuring that the company consistently meets the expectations of its valued customers.

2Distribution Network

Dawaa Drug Store LLC's distribution network is strategically centered in Abu Dhabi, with its main facility located in the Musaffah area. This location provides the company with advantageous access to key transportation routes, facilitating efficient logistics operations. The company's logistics capabilities are designed to ensure the timely and secure delivery of pharmaceutical products to various healthcare institutions, including hospitals, clinics, and pharmacies, primarily within Abu Dhabi and the broader UAE region. While the available information does not specify operations beyond the UAE, the company's established infrastructure suggests potential for future expansion into neighboring markets. (2gis.ae)

3Industry Role

Dawaa Drug Store LLC functions as a primary wholesaler in the UAE's pharmaceutical supply chain. By sourcing a wide range of pharmaceutical products from reputable manufacturers and suppliers, the company ensures their availability to healthcare professionals, hospitals, clinics, and pharmacies across the region. This role is critical in maintaining the flow of essential medications and healthcare supplies, thereby supporting the overall healthcare infrastructure in the UAE. The company's emphasis on quality and reliability underscores its commitment to meeting the diverse needs of the healthcare community.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Dawaa Drug Store Llc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Dawaa Drug Store LLC's sourcing strategy exhibits a high degree of concentration, with a significant majority of its pharmaceutical imports originating from India. Between 2022 and 2026, the company imported finished pharmaceutical formulations valued at approximately $105,000 USD, with 60 shipments across four therapeutic categories. The top five imported products include Empagliflozin ($83,000 USD), Ustekinumab ($18,000 USD), Nilotinib ($2,000 USD), and Levodopa Carbidopa ($1,000 USD). Notably, Levodopa Carbidopa accounted for 14.5% of the total import value, indicating a strategic focus on this product. The primary supplier from India is ANR Health Care Private Limited, accounting for 99.9% of the shipments, with a minor contribution from RGSK Canada Healthcare Inc.

This sourcing concentration suggests a strategic choice to maintain a streamlined supply chain with a trusted supplier. However, the heavy reliance on a single supplier may pose risks related to supply chain disruptions, pricing fluctuations, and potential regulatory changes in the supplier's country. The stability of this relationship is crucial for Dawaa Drug Store LLC's operations, and any changes in the supplier's circumstances could significantly impact the company's ability to meet market demand.

2Supply Chain Resilience

Dawaa Drug Store LLC's supply chain resilience is closely tied to its primary supplier, ANR Health Care Private Limited. The company's heavy reliance on this single supplier for the majority of its pharmaceutical imports indicates a potential vulnerability to supply chain disruptions. The absence of backup suppliers in the available data suggests a need for diversification to mitigate risks associated with supplier dependency. Additionally, the company's focus on a limited number of formulations, with 1,549 unique formulations imported, may restrict its ability to adapt to changing market demands or regulatory requirements. To enhance supply chain resilience, Dawaa Drug Store LLC could consider establishing relationships with additional suppliers and diversifying its product portfolio.

Importing Pharmaceuticals into United Arab Emirates — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United Arab Emirates

1Regulatory Authority & Framework

In the United Arab Emirates, the Ministry of Health and Prevention (MOHAP) serves as the primary regulatory authority overseeing the pharmaceutical sector. MOHAP is responsible for ensuring the safety, efficacy, and quality of medical products, including pharmaceuticals, medical devices, and health supplements. The regulatory framework governing pharmaceutical imports is outlined in the Cabinet Resolution Concerning the Executive Regulations of Federal Law Concerning Medical Products, Pharmacy Profession, and Pharmaceutical Establishments. This legislation sets forth the requirements for the registration, importation, and distribution of pharmaceutical products within the UAE. (uaelegislation.gov.ae)

The marketing authorization pathway for Indian generics involves several key steps:

1. Product Registration: Pharmaceutical products must be registered with MOHAP, providing detailed information about the product's composition, manufacturing process, and clinical data.

2. Import License: Importers must obtain an import license from MOHAP, ensuring compliance with all regulatory requirements.

3. Quality Control: Imported products are subject to quality control testing to verify their safety and efficacy.

4. Distribution Authorization: Distributors must be authorized by MOHAP to handle and distribute pharmaceutical products within the UAE.

This regulatory framework ensures that all pharmaceutical products, including generics from India, meet the stringent standards set by MOHAP, safeguarding public health in the UAE.

Import Licensing & GMP

Dawaa Drug Store Llc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Dawaa Drug Store LLC's product strategy focuses on specific therapeutic areas, including Diabetes & Endocrine, Biologics & Immunotherapy, and Advanced Oncology. The company's imports are predominantly in the Diabetes &

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — Dawaa Drug Store Llc

What products does Dawaa Drug Store Llc import from India?

Dawaa Drug Store Llc imports 4 pharmaceutical products across 4 categories. Top imports: Empagliflozin ($83.4K), Ustekinumab ($17.9K), Nilotinib ($2.4K), Levodopa Carbidopa ($1.1K).

Who supplies pharmaceuticals to Dawaa Drug Store Llc from India?

Dawaa Drug Store Llc sources from 2 verified Indian suppliers. The primary supplier is Anr Health Care Private Limited (99.9% of imports, $2.5M).

What is Dawaa Drug Store Llc's total pharmaceutical import value?

Dawaa Drug Store Llc's total pharmaceutical import value from India is $104.8K, based on 60 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Dawaa Drug Store Llc focus on?

Dawaa Drug Store Llc imports across 4 categories. The largest: Diabetes & Endocrine (79.5%), Biologics & Immunotherapy (17.1%), Advanced Oncology (2.3%).

Get Full Dawaa Drug Store Llc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.